Rare skin disease patients develop even rarer lymphoma – scientists investigate why

NCT ID NCT07477769

First seen Apr 02, 2026 · Last updated Jun 20, 2026 · Updated 17 times

Summary

This study looks at the blood immune cells of 10 adults with a rare inherited skin condition called NIPAL4 ichthyosis. Researchers want to understand why three patients with this skin disease also developed a very rare lymphoma (Sezary syndrome). By describing the normal immune cell types in these patients, they hope to find clues about a possible connection. No treatment is given; only a one-time extra blood sample is taken during routine care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEZARY SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If this study finds a distinct immune cell pattern, it could point toward a way to screen for lymphoma risk in people with NIPAL4 ichthyosis.

What could go wrong

This is a very small, early observational study with only 10 participants. It is not testing a treatment, so it may not lead to any direct medical changes.

Conditions

The condition(s) this trial relates to.

autosomal recessive congenital ichthyosis 1 Sezary syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.